shape

Pharmacology

Department of Pharmacology

A prescription for better health

OVERVIEW

Pharmacology is the branch of medical science which is concerned with the scientific study of drugs, their actions and various effects on body systems.

Considering the fact that a great majority of patient-doctor interactions conclude with prescribing a drug to the patient, the knowledge of pharmacology is the bed-rock of modern medicine.

MISSION STATEMENT:

To impart the understanding of the pharmacological basis of therapeutics, so as to enable the future doctors to prescribe rationally and make sound decisions supported by evidence based medicine.

To promote a learning and research environment that embraces inquiry and a spirit of innovation, so as to empower the health professionals to adopt a patient centered and evidence based approach to pharmacotherapy with the ultimate goal of improving human health.

The department of pharmacology aims to fulfil its mission by employing various innovative teaching learning methods along at the same time retaining the best of traditional methods of learning.

The department is well equipped with Computer Lab with Computer assisted learning (CAL) software as an alternative to animal experiments.

This in accordance with the regulations on the subject which require that the use of animals must be minimized in UG teaching.

By using CAL, the students can see the real time effects of the drugs on various body systems at the click of a button without the need for performing animal experiments which can cause much avoidable pain and distress to the animals..

Adverse Drug Reaction Monitoring Centre (AMC) in the Department of Pharmacology purpose is to monitor and report any adverse reactions that may be encountered during treatment.

The information generated will help in continuous monitoring of the risk-benefit ratio of various medicines and help in timely intervention if required.

Infrastructure and facilities
  • Experimental Pharmacology Lab:
    Used for studying drug effects through simulations or animal experiments (as per ethical guidelines).
  • Clinical Pharmacology Lab:
    Focuses on human drug trials, prescription studies, and monitoring drug responses.
  • Computer-Assisted Learning (CAL) Lab:
    Equipped with software to demonstrate drug actions virtually, reducing the need for animal use.
  • Research Laboratory:
    Supports postgraduate and faculty research in pharmacology, toxicology, and drug development.
  • Pharmacovigilance Unit:
    Collects and analyzes data on adverse drug reactions and promotes safe medicine use.
  • Demonstration Room/Classroom:
    For teaching with audiovisual aids, models, and charts to help students understand concepts better.
  • Department Library:
    Contains textbooks, journals, and reference materials for students and researchers.
Academic Activities
  • Teaching and Lectures:
    Regular theory classes for undergraduate and postgraduate students on drug action, uses, and safety.
  • Practical Sessions:
    Hands-on learning through experiments, demonstrations, and computer-assisted simulations.
  • Seminars and Journal Clubs:
    Students and faculty present and discuss current research papers and new developments in pharmacology.
  • Research Projects:
    Involvement of students and staff in experimental and clinical research on drugs and their effects.
  • Workshops and CME Programs:
    Organization of continuing medical education (CME), training sessions, and guest lectures to update knowledge.
  • Assessments and Tutorials:
    Regular internal assessments, tutorials, and discussions to strengthen understanding and application of concepts.
Services
  • Pharmacovigilance Services:
    Monitoring, reporting, and analyzing adverse drug reactions (ADRs) to ensure safe use of medicines.
  • Therapeutic Drug Monitoring (TDM):
    Measuring drug levels in patients to guide proper dosage and prevent toxicity.
  • Drug Information Services:
    Providing evidence-based information on drug use, interactions, and side effects to healthcare professionals.
  • Hospital Drug Committee Support:
    Assisting in formulary preparation, drug policy development, and promoting rational drug use in hospitals.
  • Research and Clinical Trials:
    Conducting preclinical and clinical research to evaluate new drugs and treatment methods.
  • Training and Awareness Programs:
    Organizing workshops and educational sessions on safe prescribing and drug safety for students and healthcare staff.

FACULTY

Dr. Meghna Pandey
Professor & Head of Department of Pharmacology
M.B.B.S., M.D. (Pharmacology)

Maharaja Agrasen Kedar Nath Gupta Medical College, Bahadurgarh, Haryana

Dr. Meghna Pandey is an esteemed leader in Pharmacology with over two decades of experience dedicated to medical education, clinical research, and patient safety. An alumnus of the prestigious Seth G.S. Medical College and K.E.M. Hospital, Mumbai, she has built a distinguished career spanning academic leadership and specialized clinical oversight.

In the field of medical education, Dr. Pandey has been instrumental in transitioning traditional curricula into modern, Competency-Based Medical Education (CBME). Her expertise in clinical pharmacology bridges the gap between laboratory research and bedside care, with a particular focus on drug efficacy. By committed reinforcement of monitoring systems for Adverse Drug Reactions (ADRs), she has been able to strengthen the institution’s pharmacovigilance framework.

Beyond the classroom, Dr. Pandey is a recognized authority in regulatory and ethical oversight. She has served as a key member of the Institutional Ethics Committees of Fortis Memorial Research Institute and Sheetla Multispecialty Hospital, Gurugram providing critical guidance for clinical trials.

Her research interests include adverse drug reactions, pharmacovigilance, COVID-19 therapeutics and antimicrobial resistance. She has authored multiple peer-reviewed publications and book chapters, including contributions on agranulocytosis and drugs in diagnostics. Dr. Pandey has actively participated in pharmacovigilance activities, including medical review of Individual Case Safety Reports (ICSRs) in databases such as Argus Safety for ADR reporting and training. She has played a vital role in institutional governance through her active membership in causality assessment and antimicrobial Stewardship committees.

Dr. Pandey has conducted extensive prescription audits to evaluate prescribing patterns and ensure adherence to clinical guidelines. Having organized high-impact CMEs such as the New Drugs and Clinical Trial Rules 2019, and committed to evidence-based practice and regulatory guidelines (including GCP, ICH, and updated clinical trial norms), Dr. Pandey continues to mentor students and healthcare professionals while advancing rational pharmacotherapy and patient safety in academic and clinical settings.

Publications and Presentations
  • Authored the Chapter Agranulocytosis (chapter 84) in the book “Crucial Pharmacology Trends” Vol 3; Pg -281-94
  • Authored the chapter Drugs in Diagnostics (chapter 102) in the book “Crucial Pharmacology Trends” Vol 4; Pg -146 -57
  • Sharma S, Yadav DK, Singh AK, Pandey M, Singh KK. Awareness of Digital Reporting of Adverse Drug Events among Health Care Professionals. Int J. Med. Arts. 2023; 5 (9): 3676- 81
  • Pandey M, Sharma S, Yadav DK, Gupta YK, Komal. Survey of urologists over the management of benign prostatic hyperplasia in India. Asian J. Med. Sci. 2022; 13(11): 93- 100
  • Yadav DK, Pandey M, Hazarika K. Morbidity and Mortality among health care workers due to coronavirus disease 2019. NatI J Physiol Pharm Pharmacol. 2021; 11 (5): 481-85
  • Pandey M, Sharma S, Yadav D, Kapoor V. COVID -19 Severity and treatment strategies among the Pediatric age group. E j. Pharm. med. res. 2020; 7(8): 284-90
  • Sharma S, Pandey M, Kapoor V. Containment and Pharmacological Therapies for COVID-19 Management. World J. Pharm. Res. 2020; 9 (8): 1218-24
  • Kapoor V, Yadav DK, Pandey M, Hazarika K. Antimicrobial resistance among gram negative uropathogenic bacteria. Int. J. Sci. Res. 2020; 9 (4): 54-56
  • Salwan P, Pandey M, Singla J, Salwan S, Ray S. Study and comparison of knowledge of medical students and interns about Pharmacotherapeutics. Int. j. adv. res. 2018; 6 (2): 94-99
  • Pandey M, Worlikar P, Ghosh A, Bondekar A. Comparison of healing activity of Jethimadh with Triphala on experimentally induced thermal burn wounds in rats. J. sci. soc. 2013; 40 (3): 189-190
  • Pandey M, Worlikar P, Ghosh A, Bondekar A. Comparison of wound healing activity of Jethimadh with Triphala in rats. Int. j. health allied Sci. 2012; 1 (2): 59-63
  • Ghosh A, Dhumal VR, Singh A, Pandey M, Tilak A. Effect of chronic administration of low dose aspirin on haloperidol induced catalepsy in rats. J Pharmacol Pharmacother.2011; 2 (3): 198-99
Dr. Juhi Singla
Associate Professor, Pharmacology
Maharaja Agrasen Kedar Nath Gupta Medical College, Bahadurgarh, Haryana

Dr. Juhi Singla is an accomplished medical professional with an MD in Pharmacology and extensive experience in medical education, clinical research, and pharmacovigilance.

She is currently serving as an Associate Professor in the Department of Pharmacology. She has been actively involved in undergraduate and postgraduate teaching, academic mentoring, and research activities.

With a strong foundation in clinical pharmacology, Dr. Singla possesses expertise in prescription auditing, adverse drug reaction (ADR) reporting through VigiFlow, causality assessment, and rational drug use. Her clinical exposure includes a fellowship in dialysis within the Department of Nephrology, Medanta Hospital, Gurugram providing her with valuable hands-on experience in patient management and interdisciplinary care.

Dr. Singla has demonstrated a keen interest in research, with multiple publications in reputed national and international journals. Her research work spans areas such as chronic obstructive pulmonary disease (COPD), diabetes management, pharmacoeconomics, and prescription pattern analysis.

She has also contributed to academic innovation and continues to engage in ongoing research, including experimental pharmacology studies.

Her academic journey is marked by notable achievements, including securing first place in a national-level pharmacology quiz and presenting research at prestigious conferences.

She is also certified in diabetes care through recognized international programs and has completed formal training in biomedical research, reflecting her commitment to continuous professional development.

A dedicated educator and researcher, Dr. Singla combines clinical insight with academic excellence, striving to promote evidence-based medicine, patient safety, and rational therapeutics in both teaching and practice.

Publications and Presentations
  • Sharma S, Singla J, Kumar N, Mittal V. Carbamazepine induced Toxic Epidermal Necrolysis.World J Pharm Res 2017; 6(2): 1353-8.
  • Chopra SC, Sharma S, Singla J. ATEX- A free of cost Excel based system for Attendance record and computation. J Res Med Edu and Ethics 2017; 7(1): 3-8
  • Pandey M, Salwan P, Singla J, Salwan S, Ray S. Study and comparison of knowledge of medical students and interns about pharmacotherapeutics. Int J Adv Res 2018; 6(2): 94-9.
  • Singla J, Chopra SC, Sudan DPS, Sharma S, Kumar N, Kapoor V. Comparison of formoterol-budesonide formulation nebulized alone and in combination with Ipratropium bromide in patients with COPD. Int J Adv Res 2018; 6(3): 131-6.
  • Sharma S, Chopra SC, Sharma DK, Singla J, Kapoor V. Drug prescription pattern study in patients of Diabetes mellitus in north indian tertiary care teaching hospital. Int J Basic Clin Pharmacol 2018; 7(5): 912-6.
  • Salwan P, Singla J, Salwan S. Prescription pattern in the management of chronic obstructive pulmonary disease patients in a tertiary hospital: an observational study. Int J Basic Clin Pharmacol 2020; 9(10): 1578-82.
  • Singla J, Gupta N. Pharmaco-Economic study of Oral Single Drug therapy of Anti-Hypertensive Drugs available in Indian Pharmaceutical market. J of Applied Bioanalysis. 2025; 11(11): 1165-9.
  • Singla J, Sharma S, Yadav DK. Comparison of Generic and Branded drugs on Cost effective and cost benefit analysis in a tertiary care teaching hospital. Int J Med Public Health. 2026; 16(1); 31-3.
  • Karuna, Singla J. Salivary gland lesions: A Cytomorphological study with histopathological correlation. Int J Med Phar Res. 2025; 6(4): 1538-40.
  • Singla J, Gupta N. Role of Urea Based creams in Treating Anhidrotic, Fissured and Callused skin. Afr J Biomed Res. 2024; 27(4s): 19041-3.
  • Evaluation of Acute and Subacute Anti-Inflammatory activity of Crocus Sativus Ethanolic extract water fraction in rats. – Accepted for Publication.
Dr. Ashok Kumar Jain
MBBS, DNB (General Medicine), MD (Pharmacology) Assistant Professor, Department of Pharmacology
Maharaja Agrasen Kedar Nath Gupta Medical College, Bahadurgarh, Haryana

Dr. Ashok Kumar Jain is an accomplished medical professional and academician with over 23 years of extensive clinical experience. He completed his MBBS, followed by DNB in General Medicine, and later earned his MD in Pharmacology from the University College of Medical Sciences (UCMS) and Guru Teg Bahadur (GTB) Hospital, Delhi.

Dr. Ashok Kumar Jain has been earlier associated with AIIMS Jodhpur pharmacology department. He also worked in community medicine department St. Stephens Hospital.

He also has been associated with Medical Genetics department in Sir Ganga Ram Hospital.

He currently serves as an Assistant Professor in the Department of Pharmacology at Maharaja Agrasen Kedar Nath Gupta Medical College, Bahadurgarh (Haryana). Prior to this, he worked as Senior Resident and later as Assistant Professor in Pharmacology at NC Medical College and Hospital, Haryana.

Dr. Jain has played a key role in maintaining laboratory infrastructure and equipment in compliance with institutional and regulatory standards. A skilled multitasker with excellent communication and problem-solving abilities, he has also completed the Basic Course in Medical Education (BCME) and the Basic Course in Biomedical Research (BCBR), reflecting his commitment to academic excellence and continuous learning.

He is the author of several research publications in reputed national and international journals. His primary research interests lie in the fields of Diabetes, Hypertension, and Cardiology, where he continues to contribute through both teaching and research.

Publications and Presentations
  • Ahmed GK, Darwish AM, Khalifa H, Khashbah MA. Evaluation of psychiatric comorbidity in attentiondeficit hyperactivity disorder with epilepsy: A casecontrol study. Epilepsy Res. 2021; 169:106505.
  • Katsuki D, Yamashita H, Yamane K, Kanba S, Yoshida K. Clinical Subtypes in Children with Attention-Deficit Hyperactivity Disorder According to Their Child Behavior Checklist Profile. Child Psychiatry Hum Dev. 2020; 51:969-977.
  • Rantanen K, Timonen S, Hagstrom K, Hamalainen P, Eriksson K, Nieminen P. Social competence of preschool children with epilepsy. Epilepsy Behav 2009; 14:338–43.
  • Park SH, Lee HW, Kim GE, Kim EJ. Factors Affecting Depressive Symptoms in Children and Adolescents with Epilepsy. Soa Chongsonyon Chongsin Uihak. 2022; 33:106-112.
  • Määttä H, Honkanen M, Hurtig T, Taanila A, Ebeling H, Koivumaa-Honkanen H. Childhood chronic condition and subsequent self-reported internalizing and externalizing problems in adolescence: a birth cohort study. Eur J Pediatr. 2022; 181:3377-3387.
  • Wang S, Yao B, Zhang H, Xia L, Yu S, Peng X, Xiang D, Liu Z. Comorbidity of epilepsy and attentiondeficit/hyperactivity disorder: a systematic review and meta-analysis. J Neurol. 2023; 270:4201-4213.
  • Datta AN. The impact of anti-seizure medications on psychiatric disorders among children with epilepsy: Both a challenge and an opportunity? J Can Acad Child Adolesc Psychiatry. 2023; 32:177-184.
  • Jayalakshmi S, Telugu R, Vooturi S, Patil A, Sirisha S, Somayajula S. Anxiety, depression, and psychosocial adjustment in people with epilepsy. J Neurosci Rural Pract. 2023;14:111-118.
  • Yue X, Liu XM, Chen J, Chen HY, Tan QQ, Zhou Y. The Efficacy and Cognitive Impact of Perampanel Monotherapy in Patients with Self-Limited Epilepsy with Centrotemporal Spikes: A Retrospective Analysis. Neuropsychiatr Dis Treat. 2023; 19:1263-1271.
  • Vining EP, Mellitis ED, Dorsen MM, Cataldo MF, Quaskey SA, Spielberg SP, et al. Psychologic and behavioral effects of anti-seizure medication in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics. 1987;80:165-74.
  • Baum KT, Byars AW, deGrauw TJ, Johnson CS, Perkins SM, Dunn DW, et al. Temperament, family environment, and behavior problems in children with new-onset seizures. Epilepsy Behav. 2007; 10:319-27.
  • Baum KT, Byars AW, deGrauw TJ, Dunn DW, Bates JE, Howe SR, Chiu CY, Austin JK. The effect of temperament and neuropsychological functioning on behavior problems in children with new-onset seizures. Epilepsy Behav. 2010; 17:467-73.
  • Pianta RC, Lothman DJ. Predicting behavior problems in children with epilepsy: child factors, disease factors, family stress, and child-mother interaction. Child Dev. 1994; 65:1415-28.
  • . Achenbach TM. Achenbach system of empirically based assessment (ASEBA). Manual for the child behavior checklist Pre-school (1.5–5 year), 2000 and School (6– 18 year). Burlington, USA: Research Centre for Children Youth and Families, 2001.
  • Oyegbile-Chidi T, Harvey D, Eisner J, Dunn D, Jones J, Byars A, Hermann B, Austin J. The Relationship Between Sleep, Cognition and Behavior in Children with Newly Diagnosed Epilepsy Over 36 Months. Front Neurol. 2022; 13:903137.
  • Edwards T, Scott AG, Munyoki G, et al. Active convulsive epilepsy in a rural district of Kenya: a study of prevalence and possible risk factors. Lancet Neurol. 2008; 7:50–6.
  • Kariuki SM, Abubakar A, Holding PA, Mung'ala-Odera V, Chengo E, Kihara M, Neville BG, Newton CR. Behavioral problems in children with epilepsy in rural Kenya. Epilepsy Behav. 2012; 23:41-6.
  • Piyasil V, Sriudomkajorn S, Suwanpairat J. Behavioral problems of children with epilepsy at Queen Sirikit National Institute of Child Health. J Med Assoc Thai. 2008;91 Suppl 3: S9-14.
  • Datta SS, Premkumar TS, Chandy S, Kumar S, Kirubakaran C, Gnanamuthu C, Cherian A. Behaviour problems in children and adolescents with seizure disorder: associations and risk factors. Seizure. 2005; 14:190-97.
  • Hanssen-Bauer K, Heyerdahl S, Eriksson AS. Mental health problems in children and adolescents referred to a national epilepsy center. Epilepsy Behav. 2007; 10:255- 62.
  • Gebauer-Bukurov KE, Nikolasevic ZD, Hajder DS, Zivanovic ZD, Bugarski Ignjatovic VV. Evaluation of Symptoms of Depression and Anxiety in Adolescents with Epilepsy in a Tertiary-Level Medical Center in Serbia. Ann Indian Acad Neurol. 2019; 22:419-425.
  • Sabbagh SE, Soria C, Escolano S, Bulteau C, Dellatolas G. Impact of epilepsy characteristics and behavioral problems on school placement in children. Epilepsy Behav. 2006; 9:573-8.
  • Choudhary A, Gulati S, Sagar R, Kabra M, Sapra S. Behavioral comorbidity in children and adolescents with epilepsy. J Clin Neurosci. 2014; 21:1337-40.
  • Novriska D, Sutomo, R., & Setyati, A. Behavioral problems in children with epilepsy. Paediatrica Indonesiana. 2014; 54: 324-9.
  • Matonda-Ma-Nzuzi T, Mampunza Ma Miezi S, Mpembi MN, Mvumbi DM, Aloni MN, et al. Factors associated with behavioral problems and cognitive impairment in children with epilepsy of Kinshasa, Democratic Republic of Congo. Epilepsy Behav. 2018; 78:78-83.
  • Freilinger M, Reisel B, Reiter E, Zelenko M, Hauser E, Seidl R. Behavioral and emotional problems in children with epilepsy. J Child Neurol. 2006; 21:939-45.
  • Mishra OP, Upadhyay A, Prasad R, Upadhyay SK, Piplani SK. Behavioral Problems in Indian Children with Epilepsy. Indian Pediatr. 2017; 54:116-120.
Dr. Prabhjot Kaur
MBBS (MD Physician), MD (Pharmacology)
Senior Resident, Department of Pharmacology
Maharaja Agrasen Kedar Nath Gupta Medical College, Bahadurgarh, Haryana

Dr. Prabhjot Kaur is a dedicated pharmacologist and clinician with a strong foundation in both clinical medicine and pharmacological sciences. She currently serves as Senior Resident in the Department of Pharmacology at Maharaja Agrasen Kedar Nath Gupta Medical College, Bahadurgarh, Haryana. With extensive hands-on clinical experience in critical care and a distinguished academic record, Dr. Kaur is committed to advancing medical education, rational drug use, and patient safety through teaching, research, and clinical practice.

Educational Qualifications
  • MD (Pharmacology): Santosh Medical College and Hospital, Ghaziabad (University Topper in the specialty)
  • MD Physician: National Pirogov Memorial Medical University, Vinnytsia, Ukraine.
  • Additional Certifications:
    • Basic Course in Biomedical Research (as mandated by NMC- certified by ICMR/NIE)
    • Advanced Cardiac Life Support (ACLS) and Basic Life Support (BLS) certified by NHCPS/PIM
    • Good Clinical Practice (GCP) Training Program completed through Shodh Clinicals
Professional Experience

Dr. Kaur brings vast clinical expertise gained from working in premier institutions across Delhi and Haryana:

  • Previously served at VMMC & Safdarjung Hospital, New Delhi and Deen Dayal Upadhyay govt. Hospital, New Delhi
  • Extensive experience in critical care departments at leading multispecialty hospitals, including Saroj Super Speciality Hospital (Rohini), Mata Chanan Devi Hospital (Janakpuri), SNA Multispeciality Hospital (Saket), Jain Neuro Hospital, and Metro Heart Hospital.
Academic and Research Activities (During MD Pharmacology Residency)

During her postgraduate training in MD Pharmacology at Santosh Medical College and Hospital, Dr. Kaur actively engaged in a wide range of academic and scholarly pursuits, including:

  • Conducted experimental and clinical pharmacology studies, focusing on drug efficacy, safety, and rational prescribing practices.
  • Participated in thesis research, drug assays, and adverse drug reaction monitoring.
  • Delivered seminars, journal clubs, and case-based discussions on contemporary topics in pharmacology, such as pharmacogenomics, therapeutic drug monitoring, and antimicrobial stewardship.
  • Assisted in undergraduate teaching, including lectures, practical demonstrations (e.g., pharmacy preparations, animal experiments, simulations, and clinical pharmacology exercises), and bedside clinics.
  • Contributed to departmental activities like prescription audits, drug information services, and patient counseling on rational medicine use.
  • Engaged in ethical committee reviews and promoted evidence-based medicine through critical appraisal of scientific literature.
Publications and Presentations
  • Kaur P, Dutta S, Rai RK, Agrawal A, Singhal A, et al. Evaluation of Antibiotic Usage in Pediatric Respiratory Tract Infections in a Tertiary Care Hospital: An Observational Study. SSR Institute International Journal of Life Sciences, 2025; 11(4): 8043-8048.
  • Evaluation of adverse events following immunization among Covishield recipient participants following 1st dose of vaccination during 4th National Pharmacovigilance Week at Graphic Era Institute of Medical Sciences.
  • Safety assessment of preferred antibiotics for pediatric respiratory tract infections.

These presentations reflect Dr. Kaur's commitment to disseminating knowledge on rational drug use, antimicrobial stewardship, and patient safety, earned during her postgraduate training and early career. She continues to engage in academic discussions through conferences and CME programs. Dr. Prabhjot Kaur's blend of clinical acumen and pharmacological expertise makes her an asset to the institution, fostering excellence in medical education and healthcare delivery.

Dr. Deepak Yadav
MBBS, MD (Pharmacology)
Senior Resident Department of Pharmacology
Maharaja Agrasen Kedar Nath Gupta Medical College, Bahadurgarh, Haryana

Dr. Deepak yadav is an accomplished medical professional and academician with over 8 years of extensive clinical experience. completed his MBBS from PT BD Sharma medical University Rohtak and his MD in Pharmacology from Santosh University.

He currently serves as an Senior Resident in the Department of Pharmacology at Maharaja Agrasen Kedar Nath Gupta Medical College, Bahadurgarh (Haryana). Prior to this, he worked as Senior Resident at NC Medical College and Hospital, Haryana.Also earlier associated with MAX healthcare ,World college of medical sciences, IHBAS,Manipal hospitals and RML hospital.

Dr. Yadav has played a key role in maintaining laboratory infrastructure and equipment in compliance with institutional and regulatory standards. A skilled multitasker with excellent communication and problem-solving abilities, he has also completed the Basic Course in Biomedical Research (BCBR), reflecting his commitment to academic excellence and continuous learning.

He is the author of several research publications in reputed national journals . His primary research interests lie in the fields of psychiatry.

Career Relevance:
  • Teaching and Academia:
    Graduates can work as lecturers or professors in medical, dental, or pharmacy colleges.
  • Pharmaceutical Industry:
    Opportunities in drug research, development, clinical trials, and regulatory affairs.
  • Clinical Pharmacology:
    Work in hospitals monitoring drug therapy, adverse effects, and promoting rational drug use.
  • Pharmacovigilance and Drug Safety:
    Careers in monitoring and reporting adverse drug reactions for national and international agencies.
  • Research and Public Health:
    Involvement in biomedical research, drug policy making, and public health programs.